Skip to content

Effect of a single pre-operative glucocorticosteroid injection on patients undergoing breast surgery

Role of Pre-Operative Dexamethasone in Patients Undergoing Modified Radical Mastectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012466
Enrollment
60
Registered
2018-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of carcinoma breast undergoing modified radical mastectomy

Interventions

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with carcinoma breast who are candidates for modified radical mastectomy

Exclusion criteria

Exclusion criteria: Patients having any of the following: 1. Recipients of corticosteroids/ immunoglobulins within past 4 weeks 2. Pregnancy 3. Coagulation disorders. 4. Cushings disease. 5. Uncontrolled diabetes mellitus. 6. Gastritis/ gastrointestinal ulceration 7. Severe hepatic/ renal impairment. 8. Osteoporosis. 9. Immunocompromised states. 10.Glaucoma 11.Severe systemic bacterial, viral or fungal infections. 12. Preoperative deranged cell counts, C- reactive protein or cytokine profile

Design outcomes

Primary

MeasureTime frame
Peri-operative changes in: 1.Intensity of pain as assessed on Visual Analogue Scale 2.Levels of pro-inflammatory cytokines (TNFα, IL-1β and IL-6) and anti-inflammatory cytokine (IL-10) 3.Leukocyte count 4.C-Reactive Protein Timepoint: At 6 hours and 24 hours post surgery

Secondary

MeasureTime frame
Frequency of nausea and vomitingTimepoint: At 6 hours and 24 hours post surgery

Countries

India

Contacts

Public ContactDr Hussain Amir

Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh

drazrab@yahoo.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026